Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome
Diabetology & Metabolic Syndrome volume 5, Article number: 82 (2013)
Several studies point to a correlation between obesity and the severity of depressive and anxiety symptoms in children and adults, but there are still some controversial points about this association. The aim of this study is to investigate the relationship between body composition and the severity of anxiety/depressive symptoms in overweight and obese individuals with Metabolic Syndrome (MS).
Fifty patients, 18–50 years old, overweight or obese and with the diagnosis of MS based on the International Diabetes Federation (IDF) criteria were selected for this study. Body composition was evaluated using Dual Energy X-ray Absorptiometry (DXA). Depressive symptoms were evaluated using the Hospital Anxiety and Depression Scale (HADS-Depression) and the Beck Depression Inventory (BDI). Anxiety symptoms were evaluated using HADS-Anxiety.
No correlation was found between depressive symptoms (HADS-Depression or BDI) and Body Mass Index (BMI) (r = 0.01; p = 0.94 and r = −0.12, p = 0.38; respectively), Waist Circumference (WC) (r = −0.06, p = 0.67 and r = −0.22, p = 0.12; respectively), and Waist-to-Hip Ratio (WHR) (r = −0.12, p = 0.40 and r = −0.17, p = 0.23; respectively). Additionally, no correlation was found among anxiety symptoms (HADS-Anxiety) and BMI (r = −0.15, p = 0.27), and WHR (r = −0.17, p = 0.24). In contrast, a significant correlation was found between percentage of total fat (DXA) and HADS-Depression (r = 0.34, p = 0.019) and HADS-Anxiety (r = 0.30, p = 0.039). Additionally, an inverse and strong correlation was found between lean mass (in grams) and HADS-Depression (r = −0.42, p = 0.004), HADS anxiety (r = −0.57, p < 0.0001), and BDI (r = −0.44, p = 0.026).
In individuals with MS, the percentage of body fat, and not central fat, BMI, WC, or WHR, was associated with an increased severity of anxiety and depressive symptoms. In contrast, total lean mass was strongly associated with fewer anxiety/depressive symptoms, suggesting that body composition might be related to psychiatric comorbidity in overweight individuals with MS.
The prevalence of obesity, depression, and anxiety is growing in the industrialized world . Currently, there is an epidemic of obesity in children and adults resulting mainly from a sedentary lifestyle and overeating. Metabolic Syndrome (MS) may be considered a complication of obesity. In some individuals, the accumulation of adipose tissue in the abdominal cavity (known as visceral obesity) leads to the development of impaired glucose metabolism, hypertension, and dyslipidemia see ref.  for review. The combination of these comorbidities increases the risk of complications, including psychopathological conditions [3–5].
Depression and anxiety are two of the most common psychiatric disorders. Several studies point to a correlation between obesity and the severity of depressive and anxiety symptoms in children and adults see ref. [3–5] for review, but there are still some controversial points about this association. While some studies suggest that increased weight per se is a major determinant of psychiatric symptoms [5, 6], others suggest that fat distribution may be a stronger determinant of this relationship [7, 8]. In contrast, it is also plausible to speculate that psychiatric disturbances may interfere with body fat distribution, especially by favoring visceral fat deposits. To the best of our knowledge, most of the studies have used only anthropometric variables in their analysis [5–8]. Dual energy X-ray absorptiometry (DXA) is based on the relative attenuation of two different energy X-rays and produces a three-component model of body composition comprising fat, bone mineral and lean tissue. Scans are relatively quick, involve minimal radiation exposure and also allows for regional analysis and body fat distribution . We are aware of only one previous publication utilizing DXA to evaluate body composition, to test its relationship with the severity of psychiatric symptoms in individuals with MS, and this is the focus of the present study . We therefore hypothesize that body fat and lean mass evaluated separately by DXA could better reflect the influence the association between obesity and depression/anxiety symptoms than anthropometric methods.
We evaluated a consecutive sample of fifty patients willing to lose weight who seek treatment for obesity and MS in our Institution and fulfilled eligibility criteria to participate in a study with intragastric balloon (registered at ClinicalTrials.gov; identifier: NCT01598233). The protocol was approved by the Ethics Committee of the State Institute of Diabetes and Endocrinology of Rio de Janeiro, where the patients were recruited, and written informed consent was obtained from each participant. Including criteria: age between 18 to 50 years old, be overweight or obese (Body Mass Index [BMI] ≥ 25 kg/m2) and have Metabolic Syndrome (MS) based on International Diabetes Federation (IDF) criteria .
Exclusion criteria were as follows: diabetes mellitus type 1 or 2, pregnancy or desire to become pregnant in the next six months, alcoholism, advanced liver disease, end stage renal disease, current or prior Coronary Artery Disease (defined as prior Myocardial Infarction, Stable or Unstable Angina, or coronary revascularization), current or prior cerebrovascular disease (defined as prior Ischemic Stroke, Transitory Ischemic Attack or carotid revascularization), history of psychiatric disorder, current use of antidepressants or other psychiatric medication, use of anti-obesity medications and weight loss treatment in the last 6 months. Patients were examined by an endocrinologist and provided a detailed medical history at baseline evaluation.
The following anthropometrical data were registered: body weight (kg), height (m), waist circumference (WC) and waist/hip ratio (WHR). BMI was calculated as weight divided by the square of height (kg/m2). Waist circumference (cm) was determined at the midpoint between the lowest rib and the iliac crest. WHR was defined as the ratio of waist girth to the largest circumference of the hips, measured at the trochanter major.
Evaluation of body composition
Body composition was evaluated by dual energy X-ray absorptiometry [DXA] using a Prodigy-GE densitometer (GE Healthcare, Inc., Madison, WI, USA), and included measurement of body fat content (%), fat distribution and lean mass (grams). The truncal pattern of fat distribution was characterized by preferential fat deposition in the trunk, the android pattern by fat deposition in the abdomen, and the gynoid type by fat deposition in the gluteal–femoral area . Fat Mass Ratio (FMR) was the ratio of the percentage of the trunk fat mass to the percentage of the lower limb fat mass .
Anxiety and depressive symptoms
Anxiety and depression symptoms were assessed by the Hospitalar Anxiety and Depression Scale (HADS), a self-report measurement to assess anxiety and depressive symptoms during the previous week. The items exclude somatic symptoms, avoiding overlap between somatic illness and mood disorders. It includes seven statements on each disorder (HADS-Anxiety and HADS-Depression), and each response consists of a four-point rating scale; a higher score indicates a worse condition . The Beck Depression Inventory (BDI) was also used to measure severity of depression. The instrument comprises 21 questions, each one with four answer options. The total score is the sum of the scores obtained for each individual item .
The statistical analysis was performed with GraphPad InStat 3.00 for Windows 95 (GraphPad Software, San Diego, CA, USA). Pearson’s correlation coefficient or Spearman’s correlation coefficient was used to determine the correlations between the anthropometric indicators of weight excess, including body composition, and psychiatric symptoms. Multivariate Linear Regression was used to investigate the impact of age and gender in the severity of anxiety and depressive symptoms. The level of statistical significance was set at 5% (p ≤ 0.05).
Fifty individuals (40 women), aged from 22 to 48 years old (mean 34.6 ± 7.1), with MS were evaluated. BMI ranged from 29.2 to 53.7 kg/m2 (mean 40.0 ± 6.3) and WC from 91 to 147.5 cm (mean 115.4 ± 12.8). The mean value for HADS-Anxiety was 8.4 ± 3.9, for HADS-Depression was 7.1 ± 3.3, and for BDI was 15.0 ± 7.7.
Correlation analysis was used to evaluate the relationship among anthropometric variables (i.e. BMI and WC) and body composition (Table 1). As expected, BMI presented a significant correlation with body fat. However, a significant correlation was also found between BMI and lean mass. On the other hand, a significant correlation was found only between WC and android fat. Unexpectedly, very significant correlations were between WC and lean mass.
No correlation was found between depressive symptoms (HADS depression) and BMI, WC and WHR. Also, no correlation was found among anxiety symptoms (HADS anxiety) and BMI and WHR. A negative correlation was found between anxiety symptoms and WC. Very similar results were also yielded with BDI. No correlation was found between BDI and BMI, WC and WHR. In contrast, several parameters of body composition measured by DXA were significantly associated with psychiatric symptoms, especially anxiety. These data are shown in Table 2.
Linear regression was used to investigate whether age and gender would interfere with the association among Total Body fat, Total Lean Mass and anxiety/depressive symptoms. The inverse correlation between Total Lean Mass and HADS-Anxiety remained significant even after adjustment for age and gender (p = 0.019). Similar results were yielded with Total Lean Mass and HADS-Depression, although with borderline significance (p = 0.06).
The relationship between obesity and mood disorders (especially depression) has been extensively studied in recent years, and a bidirectional association seems unequivocal . However, most of the studies have only evaluated indirect measurements of adiposity, such as BMI and WC [5–8]. These anthropometric variables, although largely used in clinical practice, may neither indicate the total body fat nor differentiate lean from fat mass. In the present study, we used DXA to determine total lean mass and the percentage of body fat and correlated these parameters with depressive and anxiety symptoms in overweight individuals with MS. Our most relevant results were the following: i – a significant correlation was found between BMI and both lean and fat mass; ii – overall, no correlation was found among anthropometric variables and psychiatric symptoms; iii - there was a direct correlation between the percentage of body fat and the severity of depressive and anxiety symptoms; and iii – there was a strong and inverse correlation between lean mass and specific psychiatric symptoms.
The relationship between total fat and psychiatric symptoms in overweight individuals is of great relevance for clinical practice. Recently, a few studies have demonstrated that depressive symptoms may be an important predictor of abdominal obesity [10, 16]. The most acceptable hypothesis for this relationship involves the hypothalamus-pituitary-adrenal (HPA) axis. As a chronic stressor, mood disorders may change cortisol secretion by stimulation of the HPA axis. This elevation in serum cortisol can increase abdominal fat deposition, promoting glucose intolerance and hypertension [16, 17]. However, the lack of correlation between depression and visceral fat has been demonstrated in the elderly . In contrast, we could demonstrate that the total amount of body fat may be more related to psychiatric symptoms than central fat per se. Because only patients with MS were included in the present study, we may speculate that we have already included patients with increased visceral fat.
One unexpected finding was the inverse relationship found between anxiety symptoms and WC. We could not find a reasonable explanation for this novel finding and we may not exclude that this may be only a false positive result. Further studies are necessary to replicate and clarify this issue.
The existence of a strong and inverse correlation between lean mass and anxiety/depressive symptoms in overweight individuals with MS, even more significant than the correlation between body fat and these same symptoms, is a novel finding with major implications. Body Mass Index is the anthropometric variable frequently used in clinical research to investigate the relationship between weight excess and psychopathology. However, major limitations of BMI include that it cannot differentiate lean from fat mass excess  and also that there may exist important ethnic-specific differences with this parameter . These limitations may be of particular relevance in men, who may present increased BMI related to muscle hypertrophy and not fat. Therefore, the use of BMI may not reflect a simple increase in total fat, and this finding may be an important confounding bias in several studies that fail to find correlations between BMI and psychiatric disorders [21, 22].
Unfortunately, our study was not powered to determine a causal relationship between lean mass and anxiety/depressive symptoms in overweight individuals with MS. We may, however, raise the hypothesis that an increase in lean mass may indicate a healthier individual and therefore be a protective factor for depressive and anxiety symptoms. This hypothesis has already been partially supported by findings of Wagner et al.  and Wallymahmed et al.  in different populations, and recently by Gubata et al.  in a young population. In contrast, one may also speculate that patients with a better psychological profile (i.e., lower rates of psychiatric symptoms) may be more prone to physical activity, which would lead to a significant increase in muscle mass. Lastly, an inverse situation also seems plausible. It has already been demonstrated that older patients with reduced lean mass (sarcopenia) may present an increased prevalence of depressive symptoms . Similar results were obtained by Kress et al. , who have demonstrated that underweight men in the U.S. military active service had increased odds of depressive symptoms. It seems reasonable to speculate that in this population, underweight men would indicate men with diminished lean mass.
Our study has a few limitations. First of all, only a small number of overweight and obese patients with MS were evaluated. This is a very selective population and further studies are necessary to confirm whether our findings would also be applicable for different populations (e.g. lean individuals, obese individuals without MS, morbidly obese patients). Second, as only 10 individuals were male, we could not determine the impact of gender in the relationship between body composition and psychiatric symptoms. Third, Prodigy densitometer does not distinct between subcutaneous and visceral fat, which might have allowed for a more thorough analysis of the role of each type of fat in the present study. Finally, physical activity might be an important confounding variable in the relationship between body composition and psychiatric symptoms. Although we did not include a specific instrument to measure physical activity, this information was obtained in the initial evaluation. None of the participants was practicing regular physical activity in the 6 months prior to study enrollment. Therefore, we may speculate that physical activity may not be an important determinant of our findings.
In conclusion, in overweight and obese individuals with MS, psychological status were directly correlated with total body and regional fat, and inversely related to lean mass. Taken together, these results suggest that the relationship between psychiatric symptoms and body weight should be carefully interpreted when only anthropometric variables are considered, especially if these variables are unable to differentiate lean from fat mass. Further and prospective studies are necessary to clarify the impact that increased lean mass, especially if associated with physical activity, would have in the psychopathological profile of larger populations.
Behn A, Ur E: The obesity epidemic and its cardiovascular consequences. Curr Opin Cardiol. 2006, 21: 353-360. 10.1097/01.hco.0000231406.84554.96.
Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008, 28 (6): 1039-1049. 10.1161/ATVBAHA.107.159228.
Kalarchian MA, Marcus MD: Psychiatric comorbidity of childhood obesity. Int Rev Psychiatry. 2012, 24 (3): 241-246. 10.3109/09540261.2012.678818.
Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB: Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012, 35 (5): 1171-1180. 10.2337/dc11-2055.
Preiss K, Brennan L, Clarke D: A systematic review of variables associated with the relationship between obesity and depression. Obes Rev. 2013, 14 (11): 906-918. 10.1111/obr.12052.
Luppino FS, De Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG: Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010, 67 (3): 220-229. 10.1001/archgenpsychiatry.2010.2.
Moreira RO, Marca KF, Appolinario JC, Coutinho WF: Increased waist circumference is associated with an increased prevalence of mood disorders and depressive symptoms in obese women. Eat Weight Disord. 2007, 12 (1): 35-40. 10.1007/BF03327770.
Labad J, Price JF, Strachan MW, Fowkes FG, Ding J, Deary IJ, Lee AJ, Frier BM, Seckl JR, Walker BR, Reynolds RM, Edinburgh Type 2 Diabetes Study Investigators: Edinburgh type 2 diabetes study investigators. Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetologia. 2010, 53 (3): 467-471. 10.1007/s00125-009-1628-9.
Woodrow G: Body composition analysis techniques in adult and pediatric patients: how reliable are they? How useful are they clinically?. Perit Dial Int. 2007, 27 (2): S245-S249.
Vogelzangs N, Kritchevsky SB, Beekman AT, Newman AB, Satterfield S, Simonsick EM, Yaffe K, Harris TB, Penninx BW: Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry. 2008, 65 (12): 1386-1393. 10.1001/archpsyc.65.12.1386.
The IDF consensus worldwide definition of the metabolic syndrome. International diabetes federation. 2006,http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf,
Blouin K, Boivin A, Tchernof A: Androgens and body fat distribution. J Steroid BiochemMol Bio. 2008, 108 (3–5): 272-280.
Valerio CM, Zajdenverg L, Oliveira JE, Mory PB, Moyses R, Godoy-Matos AF: Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr. 2012, 4 (1): 40-10.1186/1758-5996-4-40. doi:10.1186/1758-5996-4-40
Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M: Validation study of a Portuguese version of the hospital anxiety and depression scale. Psychol Health Med. 2007, 12 (2): 225-235. 10.1080/13548500500524088.
Gorenstein C, Andrade L, Vieira Filho AH, Tung TC, Artes R: Psychometric properties of the Portuguese version of the beck depression inventory on Brazilian college students. J Clin Psychol. 1999, 55: 553-562. 10.1002/(SICI)1097-4679(199905)55:5<553::AID-JCLP3>3.0.CO;2-D.
Ludescher B, Machann J, Eschweiler GW, Thamer C, Maenz C, Hipp A, Claussen CD, Schick F: Active depression is associated with regional adiposity in the upper abdomen and the neck. Int J Psychiatry Med. 2011, 41 (3): 271-280. 10.2190/PM.41.3.f.
Brown ES, Varghese FP, McEwen BS: Association of depression with medical illness: does cortisol play a role?. Biol Psychiatry. 2004, 55: 1-9.
Wong SY, Leung JC, Leung PC, Woo J: Depressive symptoms and change in abdominal obesity in the elderly: positive or negative association?. Am J Geriatr Psychiatry. 2011, 19 (8): 730-742. 10.1097/JGP.0b013e3181ff63be.
Hruschka DJ, Rush EC, Brewis AA: Population differences in the relationship between height, weight, and adiposity: an application of Burton’s model. Am J Phys Anthropol. 2013, 151 (1): 68-76. 10.1002/ajpa.22258.
Rush EC, Freitas I, Plank LD: Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr. 2009, 102 (4): 632-641. 10.1017/S0007114508207221.
Gubata ME, Urban N, Cowan DN, Niebuhr DW: A prospective study of physical fitness, obesity, and the subsequent risk of mental disorders among healthy young adults in army training. J Psychosom Res. 2013, 75 (1): 43-48. 10.1016/j.jpsychores.2013.04.003.
Chwastiak LA, Rosenheck RA, Kazis LE: Association of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans. Psychosomatics. 2011, 52: 230-236. 10.1016/j.psym.2010.12.009.
Wagner G, Rabkin J, Rabkin R: Exercise as a mediator of psychological and nutritional effects of testosterone therapy in HIV + men. Med Sci Sports Exerc. 1998, 30 (6): 811-817. 10.1097/00005768-199806000-00006.
Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH, MacFarlane IA: Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clin Endocrinol (Oxf). 1997, 47 (4): 439-446. 10.1046/j.1365-2265.1997.2801076.x.
Kim NH, Kim HS, Eun CR, Seo JA, Cho HJ, Kim SG, Choi KM, Baik SH, Choi DS, Park MH, Han C, Kim NH: Depression is associated with sarcopenia, not central obesity, in elderly korean men. J Am Geriatr Soc. 2011, 59 (11): 2062-2068. 10.1111/j.1532-5415.2011.03664.x.
Kress AM, Peterson MR, Hartzell MC: Association between obesity and depressive symptoms among U.S. Military active duty service personnel, 2002. J Psychosom Res. 2013, 60 (3): 263-271.
The authors have no competing interests to report.
EPG: Conception and design of the study, acquisition of data, drafting of the manuscript. EM: Conception and design of the study, acquisition of data, drafting of the manuscript. TTM: Conception and design of the study, acquisition of data, drafting of the manuscript. MM: Conception and design of the study, carried out DXA exams and interpretation of findings, drafting of the manuscript. ROM: Conception and design of the study, statistical analysis, interpreatation of data, drafting of the manuscript. LMCM: Carried out DXA exams and interpretation of findings, drafting of the manuscript. AFGM: supervised the entire project and provided intellectual feedback throughout. AJL: Conception and design of the study, interpretation of data, drafting of the manuscript. MLFF: supervised the entire project and provided intellectual feedback throughout. All authors read and approved the final manuscript.
About this article
Cite this article
Guedes, E.P., Madeira, E., Mafort, T.T. et al. Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome. Diabetol Metab Syndr 5, 82 (2013). https://doi.org/10.1186/1758-5996-5-82